Altimmune Inc

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Altimmune Inc
Quantité totale PI 24
Rang # Quantité totale PI 62 621
Note d'activité PI 1,9/5.0    11
Rang # Activité PI 81 291
Symbole boursier
ISIN US02155H2004
Capitalisation 647M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

13 0
1 0
9 0
1
 
Dernier brevet 2023 - Methods and compositions for vir...
Premier brevet 2004 - Novel targets and compositions f...
Dernière marque 2009 - SPARVAX
Première marque 2009 - SPARVAX

Industrie (Classification de Nice)

Derniers inventions, produits et services

2022 Invention Biodegradable polymeric particles encapsulating an active agent, pharmaceutical compositions and ...
2021 Invention Coronavirus immunogenic t cell epitope compositions and uses thereof. Provided in the present dis...
Invention Coronavirus immunogenic compositions and uses thereof. Provided in the present disclosure are imm...
Invention Rapid and prolonged immunologic-therapeutic. The present invention shows that intranasal administ...
Invention Zika and flavivirus immunogenic compositions and their use. This disclosure relates to anti-flavi...
Invention Coronavirus immunogenic compositions and uses thereof. Provided in the present disclosure are im...
2020 Invention Therapeutic agent effectiveness and its route of adminstration. Disclosed herein are methods for...
Invention Therapeutic agent effectiveness and its route of administration. Disclosed herein are methods for...
Invention Rapid and prolonged immunogic therapeutic. The present invention shows that intranasal administra...
Invention Rapid and prolonged immunologic therapeutic. The present invention shows that intranasal administ...
Invention Immunizations of avians by administration of non-replicating vectored vaccines. The present inve...
Invention Broad and long-lasting influenza vaccine. Provided herein are monovalent pharmaceutical compositi...
Invention Broad and long-lasting influenza vaccine. Provided herein are monovalent pharmaceutical composit...
2019 Invention T-cell inducing vaccine composition combination and uses thereof. Provided herein are vaccine co...
Invention T-cell inducing vaccine composition combinations and uses thereof. Provided herein are vaccine co...
Invention Peptide pharmaceuticals for treatment of nash and other disorders. The disclosure provides peptid...
2018 Invention Rapid and prolonged immunogenic-therapeutic. The present invention shows that intranasal adminis...
Invention Targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy...
2017 Invention Immunization of avians by administration of non-replicating vectored vaccines. The present invent...
Invention Methods and compositions for viral vectored gnrh vaccines to control reproduction and breeding be...
2014 Invention Methods and compositions for viral vectored vaccines. Methods and compositions are provided here...
Invention Methods and compositions for viral vectored vaccines. Methods and compositions are provided herei...
2011 Invention Immunization of avians by mucosal administration of non-replicating vectored vaccines. The prese...
2009 P/S Pharmaceutical preparations for treatment and prevention of infectious disease; pharmaceutical pr...
2006 Invention Immunization of avians by administration of non-replicating vectored vaccines. The present inven...
2004 Invention Novel targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure t...